Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer
Clinical trial NCT01622543 · COMPLETED
Trial details
- NCT number
- NCT01622543
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-26
- Primary completion
- 2017-01-18
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.